Skip to main content
Book cover

90. Kongreß pp 636–655Cite as

Hämostaseologie

  • Conference paper
  • 33 Accesses

Part of the book series: Verhandlungen der Deutschen Gesellschaft für Innere Medizin ((VDGINNERE,volume 90))

Zusammenfassung

Veränderungen der Gerinnung werden im Schock beobachtet [1, 2]. Die extremste Schockform ist die Reanimationssituation. Wir haben bei sieben Patienten mit kardialem Herzkreislauf- und Atemstillstand, die auf der internistischen Intensivstation unserer Klinik reanimiert wurden, die Koagulations- und Fibrinolyseparameter im Verlauf von vier erfolgreichen und drei erfolglosen Reanimationen bestimmt.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   74.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Matthias FR et al. (1982) Hämostaseologie 2: 26

    Google Scholar 

  2. Mittermayer Ch et al. (1978) Verh Dtsch Ges Pathol 62: 11

    PubMed  CAS  Google Scholar 

  3. Gollwitzer R (1979) Thromb Res 11: 859

    Article  Google Scholar 

  4. Bertina RM, Broekmans AW, van der Linden IK, Mertens K (1982) Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemostas 48: 1–5

    CAS  Google Scholar 

  5. Bettigole RE, Himelstein ES, Oettgen HF, Clifford GO (1970) Hypofibrinogenemia due to L-asparaginase: studies of fibrinogen survival using autologous 131I-fibrinogen. Blood 35: 195–200

    PubMed  CAS  Google Scholar 

  6. Conard J, Cazenave B, Maury J, Horellou MH, Samama M (1980) L-Asparaginase, antithrombin II, and thrombosis. Lancet 1: 1091

    Article  PubMed  CAS  Google Scholar 

  7. Gralnick HR, Henderson E (1971) Hypofibrinogenemia and coagulation factor deficiencies with L-asparaginase treatment. Cancer 27: 1313–1320

    Article  PubMed  CAS  Google Scholar 

  8. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C (1981) Deficiency of protein C in congenital thrombotic disease. J Clin Invest 68: 1370–1373

    Article  PubMed  CAS  Google Scholar 

  9. Kisiel W (1979) Human Protein C. Isolation, characterization and mechanism of activation by a-thrombin. J Clin Invest 64: 761–769

    Article  PubMed  CAS  Google Scholar 

  10. Liebman HA, Wada JK, Patch MJ, McGehee W (1982) Depression of functional and antigenic plasma antithrombin III ( AT-III) due to therapy with L-asparaginase. Cancer 50: 451–456

    Google Scholar 

  11. Pitney WR, Phadke KP, Dean S (1980) Antithrombin III deficiency during asparaginase therapy. Lancet 1: 493–494

    Article  PubMed  CAS  Google Scholar 

  12. Priest J, Edson JR, Levitt C, Tubergen D, Steinherz P, Cairo M, Bishop A, Sitarz A, White L, Coccia P, Krivit W (1981) Thrombotic complications during L-asparaginase (L-asp)-induced deficiencies of antithrombin (AT), plasminogen (PLAS), and fibrinogen (FIB) in childhood leukemia. ASCO Abstracts, C-612

    Google Scholar 

  13. Priest JR, Ramsay NKC, Bennett AJ, Krivit W, Edson JR (1982) The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia. J Pediatr 100: 990–995

    Article  PubMed  CAS  Google Scholar 

  14. Schöndorf TH, Pralle H, Graubner M, Lasch HG (1983) Antithrombin III-deficiency and thromboembolic complications under L-asparaginase treatment. Thromb Haemostas 50: 50

    Google Scholar 

  15. Vellenga E, Mulder NH, Nieweg HO (1980) Antithrombin III deficiency during asparaginase therapy. Lancet 1: 649–650

    Article  PubMed  CAS  Google Scholar 

  16. Nurden AT, Caen JP (1974) An abnormal platelet glycoprotein pattern in three cases of Glanzmann’s thrombasthenia. Br J Haematol 28: 253

    Article  PubMed  CAS  Google Scholar 

  17. Phillips DR, Jenkins CSP, Löscher EF, Larrieu MJ (1975) Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes. Nature 257: 599

    Article  PubMed  CAS  Google Scholar 

  18. Phillips DR, Agin PP (1977) Platelet membrane defects in Glanzmann’s thrombasthenia. Evidence for decreased amounts of two major glycoproteins. J Clin Invest 60: 935

    Google Scholar 

  19. White GC, Workman EF Jr, Lundblad RL (1978) Thrombin binding to thrombastenic platelets. J Lab Clin Med 91: 76

    PubMed  CAS  Google Scholar 

  20. Legrand C, Caen JP (1976) Binding of 14C-ADP by thrombastenic platelet membranes. Haemostasis 5: 231

    PubMed  CAS  Google Scholar 

  21. Mustard JF, Kinlough-Rathbone RL, Packham MA, Perry DW, Harfenist EJ, Pai KRM (1979) Comparison of fibrinogen association with normal and thrombasthenic platelets on exposure to ADP or chymotrypsin. Blood 54: 987

    PubMed  CAS  Google Scholar 

  22. Bennett JS, Vilaire G (1979) Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 64: 1393

    Article  PubMed  CAS  Google Scholar 

  23. Cross MJ (1964) Effect of fibrinogen on the aggregation of platelet by adenosine diphosphate. Thromb Haemostas 12: 524

    CAS  Google Scholar 

  24. McLean JR, Maxwell RE, Hertler D (1964) Fibrinogen and adenosine diphosphate-induced aggregation of platelets. Nature 202: 605

    Article  PubMed  CAS  Google Scholar 

  25. Polley MJ, Leung LVK, Clark FY, Nachman RL (1981) Thrombin-induced platelet membrane glycoprotein IIb and IIIa complex formation. An electron microscope study. J Exp Med 154: 1058

    Google Scholar 

  26. Greenberg JP, Packham MA, Guccione MA, Harfenist EJ, Ork JL, Kinglough-Rathbone RL, Perry DW, Mustard JF (1979) The effect of pretreatment of human or rabbit platelets with chymotrypsin on their response to human fibrinogen and aggregating agents. Blood 54: 753

    PubMed  CAS  Google Scholar 

  27. Brinkhous KM, Read MS, Mason RG (1965) Plasma thrombocyte agglutinating activity of fibrinogen. Synergism with adenosine diphosphate. Lab Invest 14: 335

    Google Scholar 

  28. Degos L, Dautigny A, Brouet JC, Colombani M, Ardaillou N, Caen JP, Colombani J (1975) A molecular defect in thrombasthenic platelets. J Clin Invest 56: 236

    Article  PubMed  CAS  Google Scholar 

  29. Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495

    Article  PubMed  Google Scholar 

  30. Santoso S, Lohmeyer J, Rennich H, Clemetson KJ, Mueller-Eckhardt C (1984) Platelet surface antigens: Analysis by monoclonal antibodies. Blut 48: 161

    Google Scholar 

  31. Santoso S: Persönliche Mitteilung

    Google Scholar 

  32. Heinrich D, Gutschank S, Mueller-Eckhardt C (1977) HLA-antibody-induced 14C-serotonin release from platelets. Vox Sang 33: 65

    Article  PubMed  CAS  Google Scholar 

  33. Kunicki TJ, Aster RH (1978) Deletion of the platelet-specific alloantigen P1A1 from platelets in Glanzmann’s thrombasthenia. J Clin Invest 61: 1225

    Article  PubMed  CAS  Google Scholar 

  34. Kunicki TJ, Aster RH (1979) Isolation and immunologic characterization of human platelet alloantigen P1A1. Mol Immunol 16: 353

    Article  PubMed  CAS  Google Scholar 

  35. Pfueller SL, Weber S, Löscher EF (1977) Studies on the mechanism of human platelets release reaction induced by immunologic stimuli. III. Relationship between the binding of soluble IgG aggregates to the Fc receptor and cell response in the presence and absence of plasma. J Immunol 118: 514

    Google Scholar 

  36. Bamberg E, Bauer O, Herrmann W, Kroemer H, Lippmann M, Müller CH, Stegmann H, Breddin KH (1978) Primärer Formwandel der Thrombozyten in vitro. Blut 37: 327–339

    Article  PubMed  CAS  Google Scholar 

  37. Bender N, Kirchmaier CM, Bartsch B, Lindenborn D, Breddin KH (1979) Stimulation of blood platelets by extracts of subcutaneous tissue. Thromb Res 14: 341–351

    Article  PubMed  CAS  Google Scholar 

  38. Kirchmaier CM, Bender N, Wilhelm B, Al Sayegh A, Breddin KH (1979) A hemostasis activating factor (HAF) in subcutaneous tissue extracts: Effects on morphologic platelet changes, platelet retention and platelet agregation. Thromb Res 16: 81–91

    Google Scholar 

  39. Kirchmaier CM, Bender N, Al Sayegh A, Breddin KH (1980) A platelet stimulating fraction in human and animal tissues. Artery 8: 416–421

    PubMed  CAS  Google Scholar 

  40. Schepping M, Jäger H, Herbst MA, Rosenthal HD, Breddin KH (1982) Änderung der Volumenverteilung der Thrombozyten unter dem Einfluß von Gewebeextrakten und von thrombozytenfunktionshemmenden Medikamenten. In: van de Loo, I., Asbeck, F. (Hrsg) Haemostase, Thrombophilie und Atherosklerose. 2. Kongreß für Thrombose und Hämostase, Münster 1982. F. K. Schattauer, Stuttgart, S. 468–471

    Google Scholar 

  41. Weichert W, Pauliks V, Breddin HK (1983) Laser induced thrombi in rat mesenteric vessels and antithrombotic drugs. Haemostasis 13: 61–71

    PubMed  CAS  Google Scholar 

  42. Rosenthal N, Vogel P (1937) Value of sternal puncture on the diagnosis of multiple myeloma. Mt Sinai J Med NY 4: 1001

    Google Scholar 

  43. Bernard J, Inceman S, Zara M, Christel D (1952) La dysglobulinémie maligne hémorragipare. Rev Hématol 7: 264

    PubMed  CAS  Google Scholar 

  44. Pachter MR, Johnson SA, Neblett TR, Truant JP (1959) Bleeding, platelets and macroglobulinemia. Am J Clin Pathol 31: 467

    PubMed  CAS  Google Scholar 

  45. Hurley R, Shaw S (1963) Observations on the haemorrhagic diathesis in multiple myeloma. Postgrad Med J 39: 480

    Article  PubMed  CAS  Google Scholar 

  46. Viala JJ, Thouverez JP, Belleville J, Revol L, Croizat P (1963) Etude de la coagulation du sang au cours des dysglobulinémies myélomes et maladie de Waldenström à propos de 48 observations. Hémostase 3: 303

    PubMed  CAS  Google Scholar 

  47. Rozenberg MC, Dintenfass L (1965) Platelet aggregation in Waldenström’s macroglobulinaemia. Thromb Haemostas 14: 202

    CAS  Google Scholar 

  48. Smith E, Kochwa S, Wasserman LR (1965) Aggregation of IgG Globulin in vivo. I. The hyperviscosity syndrome in multiple myeloma. Am J Med 39: 35

    Google Scholar 

  49. Doumenc J, Prost RJ, Samama M, Bousser J (1966) Anomalie de l’aggrégation plaquettaire au cours de la maladie de Waldenström (à propos de 3 cas). Nouv Rev Fr Hematol Blood Cells 6: 734

    CAS  Google Scholar 

  50. Kopp WL, Beirne GJ, Burns RO (1967) Hyperviscosity syndrome in multiple myeloma. Am J Med 43: 141

    Article  PubMed  CAS  Google Scholar 

  51. Vigliano EW, Horowitz HI (1967) Bleeding syndrome in a patient with IgA myeloma: Interaction of protein and connective tissue. Blood 29: 823

    Google Scholar 

  52. Cohen I, Amir J, Ben-Shaul Y, Pick A, De Vries A (1970) Plasma cell myeloma associated with an unusual myeloma protein causing impairment of fibrin aggregation and platelet function in a patient with multiple malignancy. Am J Med 48: 766

    Article  PubMed  CAS  Google Scholar 

  53. Perkins HA, McKenzie MR, Fudenberg HH (1970) Hemostatic defects in dysproteinaemias. Blood 35: 695

    PubMed  CAS  Google Scholar 

  54. Benninger GW, Kreps SI (1971) Aggregation phenomenon in an IgG multiple myeloma resulting in the hyperviscosity syndrome. Am J Med 51: 287

    Article  PubMed  CAS  Google Scholar 

  55. Penny R, Castaldi PA, Whitsed HM (1971) Inflammation and haemostasis in paraproteinaemias. Br J Haematol 20: 35

    Article  PubMed  CAS  Google Scholar 

  56. Pruzanski W, Watt JG (1972) Serum viscosity and hyperviscosity syndrome in IgG multiple myeloma. Ann Intern Med 77: 853

    Article  PubMed  CAS  Google Scholar 

  57. Tuddenham EGD, Whittaker JA, Bradley J, Lilleyman JS, James DR (1974) Hyperviscosity syndrome in IgA multiple myeloma. Br J Haematol 27: 65

    Article  PubMed  CAS  Google Scholar 

  58. Harbaugh ME, Hill EM, Conn RB (1975) Antithrombin and antithromboplastin activity accompanying IgG myeloma. Am J Clin Pathol 63: 57

    PubMed  CAS  Google Scholar 

  59. Deutsch E, Neumann E, Niessner H (1976) Zur Pathogenese der hämorrhagischen Diathesen bei monoklonalen Gammopathien. In: Löffler H (Hrsg) Maligne Lymphome und monoklonale Gammopathien, Reihe: Hämatologie und Bluttransfusion, Bd 18. JF Lehmanns, München, S. 357

    Google Scholar 

  60. Roberts-Thomson PJ, Mason DY, Mac Lennan ICM (1976) Relationship between paraprotein polymerization and clinical features in IgA myeloma. Br J Haematol 33: 117

    Article  PubMed  CAS  Google Scholar 

  61. Kasturi J, Saraya AK (1978) Platelet functions in dysproteinaemia. Acta Haematol (Basel) 59: 104

    Article  CAS  Google Scholar 

  62. McGrath KM, Stuart JJ, Richards F (1979) Correlation between serum-IgG, platelet membrane IgG and platelet function in hypergammaglobulinaemic states. Br J Haematol 42: 585

    Article  PubMed  CAS  Google Scholar 

  63. Hedge UM, Powell DK, Bowes A, Gordon-Smith EC (1981) Enzyme linked immunoassay for the detection of platelet associated IgG. Br J Haematol 48: 39

    Google Scholar 

  64. Landolfi R, Leone G, Fedeli G, Storti S, Laghi F, Bizzi B (1980) Platelet associated IgG in acute and chronic hepatic diseases. Scand J Haematol 25: 417

    Article  PubMed  CAS  Google Scholar 

  65. Mueller-Eckhardt C, Kayser W, Mersch-Baumert K, Mueller-Eckhardt G, Breidenbach M, Kugel H-G, Graubner M (1980) The clinical significance of platelet associated IgG: a study on 298 patients with various disorders. Br J Haematol 46: 123

    Article  PubMed  CAS  Google Scholar 

  66. Kayser W (1981) Immunoglobulin G und Komplementfaktoren an menschlichen Thrombozyten: Pathogenetische, diagnostische und klinische Aspekte. Inaug.-Diss. Gießen

    Google Scholar 

  67. Morse BS, Ginliani D, Nussbaum M (1981) Quantitation of Platelet-associated IgG by radial immunodiffusion. Blood 57: 809

    PubMed  CAS  Google Scholar 

  68. Hedge UM, Williams K, Devereux S, Bowes A (1983) Platelet associated IgG and immune thrombocytopenia in lymphoproliferative and autoimmune disorders. Clin Lab Haematol 5: 9

    Google Scholar 

  69. Kelton JG, Giles AR, Neam PB, Powers P, Hageman N, Hirsh J (1980) Comparison of two direct assays for PAIgG in assessment of immune and nonimmune thrombocytopenia. Blood 55: 424

    PubMed  CAS  Google Scholar 

  70. Kelton JG, Steeves K (1983) The amount of platelet-bound albumin parallels the amount of IgG on washed platelets from patients with immune thrombocytopenia. Blood 62: 924

    PubMed  CAS  Google Scholar 

  71. Shulman NR, Leisinger CA, Hotchkiss AJ, Kautz CA (1983) The nonspecific nature of platelet-associated IgG. Trans Assoc Am Physicians 95: 213

    Google Scholar 

  72. Mueller-Eckhardt C, Schulz G, Sauer K-H, Dienst C, Mahn J (1978) Studies on the platelet radioactive immunoglobulin test. J Immunol Methods 19: 1

    Article  PubMed  CAS  Google Scholar 

  73. Mueller-Eckhardt C, Mueller-Eckhardt G, Kayser W, Voss RM, Wegner J, Kiienzlen E (1982) Platelet associated IgG, platelet survival, and platelet sequestration in thrombocytopenic states. Br J Haematol 52: 49

    Article  PubMed  CAS  Google Scholar 

  74. McGregor JL, Brochier J, Wild F, Follea G, Trzeciak MC, James E, Dechavanne M, McGregor L, Clemetson KJ (1983) Monoclonal antibodies against platelet membrane glycoproteins. Characterization and effect on platelet function. Eur J Biochem 131: 427

    Google Scholar 

  75. Scharf T, Santoso S, Rennich H, Heinrich D, Mueller-Eckhardt C (1984) Einfluß monoklonaler, Glykoprotein llb/Ills-and Zw(a)-spezifischer Antikörper auf die Plättchenfunktion. Blut (im Druck )

    Google Scholar 

  76. Born GVR, Cross MI (1963) The aggregation of blood platelets. J Physiol 168: 178–195

    PubMed  CAS  Google Scholar 

  77. Breddin K, Bürck KH (1963) Zur Klinik der Thrombozytenfunktionsstörungen unter besonderer Berücksichtigung der Ausbreitungsfähigkeit der Thrombozyten an silikonisierten Glasflächen. Thromb Haemostas 9: 525–545

    Google Scholar 

  78. Crea F, Chierchia R, Caterina R de, Bernini W, Giannesi, Maseri A (1981) Antiplatelet effects of isosorbide dinitrate ( ISDN) in man. Eur Heart J (Suppl A) 2: 53

    Google Scholar 

  79. Levin RI, Jaffe EA, Weksler BB, Tack-Goldmann K (1981) Nitroglycerin stimulates synthesis of prostacyclin by cultured human endothelial cells. J Clin Invest 67: 762–769

    Article  PubMed  CAS  Google Scholar 

  80. Ring T, Knudsen F, Kristensen SD, Larsen CE (1983) Nitroglycerin prolongs the bleeding time in healthy males. Thromb Res 29: 553–559

    Article  PubMed  CAS  Google Scholar 

  81. Schafer AI, Alexander RW, Handin RI (1980) Inhibition of platelet function by organic nitrate vasodilatators. Blood 55: 649–654

    PubMed  CAS  Google Scholar 

  82. Schrör K, Grodzinska L, Darius H (1981) Stimulation of coronary vascular prostacyclin and inhibition of human platelet thromboxane A2 after low dose nitroglycerin. Thromb Res 23: 59–67

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Klaubert, W. et al. (1984). Hämostaseologie. In: 90. Kongreß. Verhandlungen der Deutschen Gesellschaft für Innere Medizin, vol 90. J.F. Bergmann-Verlag, Munich. https://doi.org/10.1007/978-3-642-85457-6_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85457-6_28

  • Publisher Name: J.F. Bergmann-Verlag, Munich

  • Print ISBN: 978-3-8070-0342-9

  • Online ISBN: 978-3-642-85457-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics